A novel approach to oral iron delivery using ferrous sulphate loaded solid lipid nanoparticles

International Journal of Pharmaceutics

Volumn 456, Issue 2, 2013, Pages 400-407

  Zariwala, M Gulrez ^a   Elsaid, Naba ^b   Jackson, Timothy L ^c   Corral López, Francisco ^b   Farnaud, Sebastien ^d   Somavarapu, Satyanarayana ^b   Renshaw, Derek ^a  

^a UNIVERSITY OF WESTMINSTER   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF BEDFORDSHIRE   (United Kingdom)

Author keywords

Caco 2; Chitosan; Ferritin; Ferrous sulfate; Iron supplementation; Solid lipid nanoparticles

Indexed keywords

CHITOSAN; FERROUS SULFATE; IRON; STEARIC ACID;

ARTICLE; CELL VIABILITY; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IRON ABSORPTION; IRON TRANSPORT; LIPID VESICLE; MISCIBILITY; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

CACO-2; CHITOSAN; FERRITIN; FERROUS SULFATE; IRON SUPPLEMENTATION; SOLID LIPID NANOPARTICLES;

ADMINISTRATION, ORAL; CACO-2 CELLS; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; FERROUS COMPOUNDS; HUMANS; IRON; LIPIDS; NANOPARTICLES;

EID: 84886726407     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.08.070     Document Type: Article

References (62)

1. X. Alvarez-Hernandez, G.M. Nichols, and J. Glass Caco-2 cell line: a system for studying intestinal iron transport across epithelial cell monolayers Biochim. Biophys. Acta Biomembranes 1070 1991 205 208
2. N.C. Andrews Disorders of iron metabolism N. Engl. J. Med. 341 1999 1986 1995 (Pubitemid 30010408)
3. B.J. Aungst Intestinal permeation enhancers J. Pharm. Sci. 89 2000 429 442
4. A. Bargoni, R. Cavalli, G.P. Zara, Fundarò, O. Caputo, and M.R. Gasco Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II-tissue distribution Pharmacol. Res. 43 2001 497 502 (Pubitemid 32578867)
5. S.C. Bhatia, N. Ravi, and A. Mössbauer Study of the interaction of chitosan and d-glucosamine with iron and its relevance to other metalloenzymes Biomacromolecules 4 2003 723 727 (Pubitemid 36701244)
6. G.A. Castro, A.L.Z. Coelho, C.A. Oliveira, G.A.B. Mahecha, R.L. Oréficec, and L.A.M. Ferreira Formation of ion pairing as an alternative to improve encapsulation and stability and to reduce skin irritation of retinoic acid loaded in solid lipid nanoparticles Int. J. Pharm. 381 2009 77 83
7. R. Cavalli, O. Caputo, M.E. Carlotti, M. Trotta, C. Scarnecchia, and M.R. Gasco Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles Int. J. Pharm. 148 1997 47 54 (Pubitemid 27152216)
8. Y. Chen, and L. Liu Modern methods for delivery of drugs across the blood-brain barrier Adv. Drug. Deliv. Rev. 64 2012 640 665
9. P.P. Constantinides, and K.M. Wasan Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: in vitro/in vivo case studies J. Pharm. Sci. 96 2007 235 248 (Pubitemid 46363554)
10. W.H. Crosby The rationale for treating iron deficiency anemia Arch. Intern. Med. 144 1984 471 472 (Pubitemid 14152722)
11. S. Das, W.K. Ng, P. Kanaujia, S. Kim, and R.B.H. Tan Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables Colloids Surf. B Biointerfaces 88 2011 483 489
12. M. Demirel, Y. Yazan, R.H. Müller, F. Kiliç, and B. Bozan Formulation and in vitro-in vivo evaluation of piribedil solid lipid micro- and nanoparticles J. Microencapsul. 18 2001 359 371 (Pubitemid 32285032)
13. J. Dintaman, and J. Silverman Inhibition of P-glycoprotein by d-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS) Pharm. Res. 16 1999 1550 1556 (Pubitemid 29510551)
14. J.H. Eldridge, C.J. Hammond, J.A. Meulbroek, J.K. Staas, R.M. Gilley, and T.R. Tice Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches J. Control. Release 11 1990 205 214 (Pubitemid 20070098)
15. S. Fairweather-Tait, I. Phillips, G. Wortley, L. Harvey, and R. Glahn The use of solubility, dialyzability, and Caco-2 cell methods to predict iron bioavailability Int. J. Vitam. Nutr. Res. 77 2007 158 165 (Pubitemid 47607424)
16. W.W. Fish Rapid colorimetric micromethod for the quantitation of complexed iron in biological samples Methods Enzymol. 158 1988 357 364
17. P. Fonte, T. Nogueira, C. Gehm, D. Ferreira, and B. Sarmento Chitosan-coated solid lipid nanoparticles enhance the oral absorption of insulin Drug Deliv. Transl. Res. 1 2011 299 308
18. A. Fundarò, R. Cavalli, A. Bargoni, D. Vighetto, G.P. Zara, and M.R. Gasco Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats Pharmacol. Res. 42 2000 337 343
19. R.P. Glahn, M.B. Gangloff, D.R. Van Campen, D.D. Miller, E.M. Wien, and W.A. Norvell Bathophenanthrolene disulfonic acid and sodium dithionite effectively remove surface-bound iron from Caco-2 cell monolayers J. Nutr. 125 1995 1833 1840
20. S.M. Grundy Influence of stearic acid on cholesterol metabolism relative to other long-chain fatty acids Am. J. Clin. Nutr. 60 1994 986S 990S
21. Q. Guan, Q. Guan, T. Lin, and J. Yin Preparation and pharmacokinetics of solid lipid nanoparticles loaded with pueraria flavones J. Control. Release 152 Supplement 1 2011 e25 e26
22. L.G. Hermida, A. Roig, C. Bregni, M. Sabés-Xamaní, and R. Barnadas-Rodríguez Preparation and characterization of iron-containing liposomes: their effect on soluble iron uptake by Caco-2 cells J. Liposome Res. 21 2010 203 212
23. B. Heurtault, P. Saulnier, B. Pech, J.E. Proust, and J.P. Benoit Physico-chemical stability of colloidal lipid particles Biomaterials 24 2003 4283 4300 (Pubitemid 36814076)
24. R.F. Hurrell, S. Lynch, T. Bothwell, H. Cori, R. Glahn, E. Hertrampf, Z. Kratky, D. Miller, M. Rodenstein, H. Streekstra, B. Teucher, E. Turner, C.K. Yeung, M.B. Zimmermann, and null Enhancing the absorption of fortification iron. A sustain task force report Int. J. Vitam. Nutr. Res. 74 2004 387 401 (Pubitemid 40203617)
25. I.P. Kaur, R. Bhandari, S. Bhandari, and V. Kakkar Potential of solid lipid nanoparticles in brain targeting J. Control. Release 127 2008 97 109
26. S.J. Lim, and C.K. Kim Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid Int. J. Pharm. 243 2002 135 146
27. G. Lukowski, J. Kasbohm, P. Pflegel, A. Illing, and H. Wulff Crystallographic investigation of cetylpalmitate solid lipid nanoparticles Int. J. Pharm. 196 2000 201 205 (Pubitemid 30105743)
28. C.F. Luo, M. Yuan, M.S. Chen, S.M. Liu, L. Zhu, B.Y. Huang, X.W. Liu, and W. Xiong Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration Int. J. Pharm. 410 2011 138 144
29. R.H. Müller, W. Mehnert, J.S. Lucks, C. Schwarz, A. zur Mühlen, H. Weyhers, C. Freitas, and D. Rühl Solid lipid nanoparticles (SLN) - an alternative colloidal carrier system for controlled drug delivery Eur. J. Pharm. 41 1995 62 69
30. R.H. Müller, M. Radtke, and S.A. Wissing Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations Adv. Drug Deliv. Rev. 54 Supplement 2002 S131 S155
31. R. Müller, D. Rühl, S. Runge, K. Schulze-Forster, and W. Mehnert Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant Pharm. Res. 14 1997 458 462 (Pubitemid 27205004)
32. N. Martnez-Navarrete, M.M. Camacho, J. Martnez-Lahuerta, J. Martnez-Monzo, and P. Fito Iron deficiency and iron fortified foods - a review Food Res. Int. 35 2 2002 225 231 (Pubitemid 34161567)
33. W. Mehnert, and K. Mäder Solid lipid nanoparticles: production, characterization and applications Adv. Drug Deliv. Rev. 47 2001 165 196 (Pubitemid 32324113)
34. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63 (Pubitemid 14203433)
35. S.V. Mussi, R.C. Silva, M.N.C.D. Oliveira, C.M. Lucci, R.B.D. Azevedo, and L.A.N.M. Ferreira New approach to improve encapsulation and antitumor activity of doxorubicin loaded in solid lipid nanoparticles Eur. J. Pharm. Sci. 48 2013 282 290
36. M. Nassimi, C. Schleh, H.D. Lauenstein, R. Hussein, H.G. Hoymann, W. Koch, G. Pohlmann, N. Krug, K. Sewald, S. Rittinghausen, A. Braun, and C. Müller-Goymann A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung Eur. J. Pharm. Biopharm. 75 2010 107 116
37. P.R. Nepal, M.K. Chun, and H.K. Choi Preparation of floating microspheres for fish farming Int. J. Pharm. 341 2007 85 90 (Pubitemid 47088111)
38. H.T. Osborn, and C.C. Akoh Structured lipids-novel fats with medical nutraceutical, and food applications Compr. Rev. Food Sci. Food Saf. 1 2002 110 120
39. M.O. Oyewumi, R.A. Yokel, M. Jay, T. Coakley, and R.J. Mumper Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice J. Control. Release 95 2004 613 626 (Pubitemid 38340510)
40. K. Ruckmani, and V. Sankar Formulation and optimization of zidovudine niosomes AAPS Pharm. Sci. Tech. 11 2010 1119 1127
41. L. Saha, P. Pandhi, S. Gopalan, S. Malhotra, and P.K. Saha Comparison of efficacy, tolerability, and cost of iron polymaltose complex with ferrous sulphate in the treatment of iron deficiency anemia in pregnant women Med. Gen. Med. 9 2007 1
42. V. Sanna, N. Kirschvink, P. Gustin, E. Gavini, I. Roland, L. Delattre, and B. Evrard Preparation and in vivo toxicity study of solid lipid microparticles as carrier for pulmonary administration AAPS Pharm. Sci. Tech. 5 2004 e27
43. K. Schümann, T. Ettle, B. Szegner, B. Elsenhans, and N.W. Solomons On risks and benefits of iron supplementation recommendations for iron intake revisited J. Trace Elem. Med. Biol. 21 2007 147 168 (Pubitemid 47241218)
44. P. Severino, T. Andreani, A.S. Macedo, J.F. Fangueiro, M.H. Santana, A.M. Silva, and E.B. Souto Current state-of-art and new trends on lipid nanoparticles (SLN and NLC) for oral drug delivery J. Drug Deliv. 2012 750891
45. P. Sharp Methods and options for estimating iron and zinc bioavailability using Caco-2 cell models: benefits and limitations Int. J. Vitam. Nutr. Res. 75 2005 413 421
46. A.C. Silva, E. González-Mira, M.L. García, M.A. Egea, J. Fonseca, R. Silva, D. Santos, E.B. Souto, and D. Ferreira Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound Colloids Surf. B Biointerfaces 86 2011 158 165
47. S. Singh, A.K. Dobhal, A. Jain, J.K. Pandit, and S. Chakraborty Formulation and evaluation of solid lipid nanoparticles of a water soluble drug: zidovudine Chem. Pharm. Bull. 58 2010 650 655
48. T.L. Slager, and F.M. Prozonic Simple methods for calibrating IR in TGA/IR analyses Thermochim. Acta 426 2005 93 99 (Pubitemid 40127400)
49. V. Snoeck, B. Goddeeris, and E. Cox The role of enterocytes in the intestinal barrier function and antigen uptake Microbes Infect. 7 2005 997 1004 (Pubitemid 40982667)
50. E. Souto, and R. Müller M. Schäfer-Korting, Lipid Nanoparticles: Effect on Bioavailability and Pharmacokinetic Changes 2010 Springer Berlin, Heidelberg 115 141
51. H. Takeuchi, Y. Matsui, H. Yamamoto, and Y. Kawashima Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats J. Control. Release 86 2003 235 242 (Pubitemid 36084273)
52. B. Thompson, P. Sharp, R. Elliott, S. Al Mutairi, and S.J. Fairweather-Tait Development of a modified Caco-2 cell model system for studying iron availability in eggs J. Agric. Food Chem. 58 2010 3833 3839
53. U.S. FDA Code of Federal Regulations. Title 21, Volume 3. Revised as of April 1, 2013. CITE: 21CFR184.1090 [48 FR 52445, Nov. 18, 1983, as amended at 50 FR 49536, Dec. 3, 1985; 69 FR 24512, May 4, 2004. http://www.accessdata.fda. gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=184.1090.
54. Y. Wang, L. Zhu, Z. Dong, S. Xie, X. Chen, M. Lu, X. Wang, X. Li, and W. Zhou Preparation and stability study of norfloxacin-loaded solid lipid nanoparticle suspensions Colloids Surf. B Biointerfaces 98 2012 105 111
55. S. Xia, and S. Xu Ferrous sulfate liposomes: preparation, stability and application in fluid milk Food Research International 38 2005 289 296 (Pubitemid 40118104)
56. S. Yang, J. Zhu, Y. Lu, B. Liang, and C. Yang Body distribution of camptothecin solid lipid nanoparticles after oral administration Pharm. Res. 16 1999 751 757 (Pubitemid 29227107)
57. B. Yu, Y. Zhang, W. Zheng, C. Fan, and T. Chen Positive surface charge enhances selective cellular uptake and anticancer efficacy of selenium nanoparticles Inorg. Chem. 51 2012 8956 8963
58. H. Yuan, J. Chen, Y.Z. Du, F.Q. Hu, S. Zeng, and H.L. Zhao Studies on oral absorption of stearic acid SLN by a novel fluorometric method Colloids Surf. B Biointerfaces 58 2007 157 164 (Pubitemid 46921452)
59. G.P. Zara, R. Cavalli, A. Bargoni, A. Fundarò, D. Vighetto, and M.R. Gasco Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues J. Drug Target 10 2002 327 335 (Pubitemid 34746314)
60. Q. Zhang, G. Yie, Y. Li, Q. Yang, and T. Nagai Studies on the cyclosporin A loaded stearic acid nanoparticles Int. J. Pharm. 200 2000 153 159 (Pubitemid 30364902)
61. M.B. Zimmermann, and R.F. Hurrell Nutritional iron deficiency Lancet 370 2007 511 520 (Pubitemid 47214636)
62. M.G. Zariwala, S. Somavarapu, S. Farnaud, and D. Renshaw Comparison study of oral iron preparations using a human intestinal model Sci. Pharm. 2013 10.3797/scipharm.1304-03 (in press)